• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菌群失调诱导的肠道炎症激活肿瘤坏死因子受体I并介导小鼠酒精性肝病。

Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice.

作者信息

Chen Peng, Stärkel Peter, Turner Jerrold R, Ho Samuel B, Schnabl Bernd

机构信息

Department of Medicine, University of California San Diego, La Jolla, CA.

出版信息

Hepatology. 2015 Mar;61(3):883-94. doi: 10.1002/hep.27489. Epub 2015 Jan 30.

DOI:10.1002/hep.27489
PMID:25251280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4340725/
Abstract

UNLABELLED

Intestinal barrier dysfunction is an important contributor to alcoholic liver disease (ALD). Translocated microbial products trigger an inflammatory response in the liver and contribute to steatohepatitis. Our aim was to investigate mechanisms of barrier disruption after chronic alcohol feeding. A Lieber-DeCarli model was used to induce intestinal dysbiosis, increased intestinal permeability, and liver disease in mice. Alcohol feeding for 8 weeks induced intestinal inflammation in the jejunum, which is characterized by an increased number of tumor necrosis factor alpha (TNF-α)-producing monocytes and macrophages. These findings were confirmed in duodenal biopsies from patients with chronic alcohol abuse. Intestinal decontamination with nonabsorbable antibiotics restored eubiosis, decreased intestinal inflammation and permeability, and reduced ALD in mice. TNF-receptor I (TNFRI) mutant mice were protected from intestinal barrier dysfunction and ALD. To investigate whether TNFRI on intestinal epithelial cells mediates intestinal barrier dysfunction and ALD, we used TNFRI mutant mice carrying a conditional gain-of-function allele for this receptor. Reactivation of TNFRI on intestinal epithelial cells resulted in increased intestinal permeability and liver disease that is similar to wild-type mice after alcohol feeding, suggesting that enteric TNFRI promotes intestinal barrier dysfunction. Myosin light-chain kinase (MLCK) is a downstream target of TNF-α and was phosphorylated in intestinal epithelial cells after alcohol administration. Using MLCK-deficient mice, we further demonstrate a partial contribution of MLCK to intestinal barrier dysfunction and liver disease after chronic alcohol feeding.

CONCLUSION

Dysbiosis-induced intestinal inflammation and TNFRI signaling in intestinal epithelial cells mediate a disruption of the intestinal barrier. Therefore, intestinal TNFRI is a crucial mediator of ALD.

摘要

未标记

肠屏障功能障碍是酒精性肝病(ALD)的一个重要促成因素。易位的微生物产物会引发肝脏中的炎症反应,并导致脂肪性肝炎。我们的目的是研究慢性酒精喂养后屏障破坏的机制。采用Lieber-DeCarli模型诱导小鼠肠道菌群失调、肠道通透性增加和肝病。酒精喂养8周可诱导空肠发生肠道炎症,其特征是产生肿瘤坏死因子α(TNF-α)的单核细胞和巨噬细胞数量增加。这些发现已在慢性酒精滥用患者的十二指肠活检中得到证实。用不可吸收的抗生素进行肠道去污可恢复正常菌群,减轻肠道炎症和通透性,并减轻小鼠的ALD。TNF受体I(TNFRI)突变小鼠可免受肠屏障功能障碍和ALD的影响。为了研究肠上皮细胞上的TNFRI是否介导肠屏障功能障碍和ALD,我们使用了携带该受体条件性功能获得等位基因的TNFRI突变小鼠。肠上皮细胞上TNFRI的重新激活导致肠道通透性增加和肝病,类似于酒精喂养后的野生型小鼠,这表明肠道TNFRI促进肠屏障功能障碍。肌球蛋白轻链激酶(MLCK)是TNF-α的下游靶点,在给予酒精后在肠上皮细胞中被磷酸化。使用MLCK缺陷小鼠,我们进一步证明了MLCK在慢性酒精喂养后对肠屏障功能障碍和肝病有部分作用。

结论

菌群失调诱导的肠道炎症和肠上皮细胞中的TNFRI信号传导介导了肠屏障的破坏。因此,肠道TNFRI是ALD的关键介质。

相似文献

1
Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice.菌群失调诱导的肠道炎症激活肿瘤坏死因子受体I并介导小鼠酒精性肝病。
Hepatology. 2015 Mar;61(3):883-94. doi: 10.1002/hep.27489. Epub 2015 Jan 30.
2
Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.肠道 HIF-1α 缺失通过诱导肠道菌群失调和屏障功能障碍加重酒精性肝病。
J Hepatol. 2018 Oct;69(4):886-895. doi: 10.1016/j.jhep.2018.05.021. Epub 2018 May 25.
3
Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice.Toll 样受体 2 介导的肠道损伤和肠肿瘤坏死因子受体 I 有助于小鼠肝纤维化。
Gastroenterology. 2012 Nov;143(5):1330-1340.e1. doi: 10.1053/j.gastro.2012.07.099. Epub 2012 Jul 27.
4
Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition.肿瘤坏死因子诱导的肠道屏障功能丧失需要 TNFR1 和 TNFR2 信号在全胃肠外营养的小鼠模型中。
J Physiol. 2013 Aug 1;591(15):3709-23. doi: 10.1113/jphysiol.2013.253518. Epub 2013 Jun 10.
5
1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.1,25-二羟基维生素D通过调节肌球蛋白轻链激酶信号通路保护肠上皮屏障。
Inflamm Bowel Dis. 2015 Nov;21(11):2495-506. doi: 10.1097/MIB.0000000000000526.
6
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.肠通透性、微生物易位、十二指肠和粪便微生物群的变化及其与人类酒精性肝病进展的关系。
Gut Microbes. 2020 Nov 9;12(1):1782157. doi: 10.1080/19490976.2020.1782157. Epub 2020 Jun 26.
7
Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.补充饱和长链脂肪酸可维持小鼠肠道微生态平衡并减轻乙醇诱导的肝损伤。
Gastroenterology. 2015 Jan;148(1):203-214.e16. doi: 10.1053/j.gastro.2014.09.014. Epub 2014 Sep 16.
8
Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity.醋酸锌和利福昔明联合治疗通过维持肠道屏障完整性预防乙醇诱导的肝纤维化。
World J Gastroenterol. 2021 Dec 28;27(48):8323-8342. doi: 10.3748/wjg.v27.i48.8323.
9
Role of snail activation in alcohol-induced iNOS-mediated disruption of intestinal epithelial cell permeability.蜗牛激活在酒精诱导的 iNOS 介导的肠道上皮细胞通透性破坏中的作用。
Alcohol Clin Exp Res. 2011 Sep;35(9):1635-43. doi: 10.1111/j.1530-0277.2011.01510.x. Epub 2011 Apr 27.
10
Alcoholic liver disease: the gut microbiome and liver cross talk.酒精性肝病:肠道微生物群与肝脏的相互作用
Alcohol Clin Exp Res. 2015 May;39(5):763-75. doi: 10.1111/acer.12704.

引用本文的文献

1
Ferroptosis and gut microbiota: A new horizon in alcohol-associated liver disease management.铁死亡与肠道微生物群:酒精性肝病管理的新视野。
Cell Mol Life Sci. 2025 Jul 19;82(1):282. doi: 10.1007/s00018-025-05815-5.
2
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease.对致病共生菌毒力因子的靶向抑制可减轻酒精性肝病。
Cell Host Microbe. 2025 Jun 11;33(6):957-972.e6. doi: 10.1016/j.chom.2025.05.003. Epub 2025 May 28.
3
Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis.肠道微生物群在增强酒精性肝硬化炎症及预测预后中的作用
Gastroenterol Clin North Am. 2025 Jun;54(2):453-467. doi: 10.1016/j.gtc.2024.12.001. Epub 2025 Jan 18.
4
Role of Nutrition in the Management of Chronic Liver Disease.营养在慢性肝病管理中的作用。
Gastro Hep Adv. 2025 Jan 2;4(5):100613. doi: 10.1016/j.gastha.2024.100613. eCollection 2025.
5
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy.肠道微生物群失调:发病机制、疾病、预防与治疗
MedComm (2020). 2025 Apr 18;6(5):e70168. doi: 10.1002/mco2.70168. eCollection 2025 May.
6
Influence of Alcohol on the Intestinal Immune System.酒精对肠道免疫系统的影响。
Alcohol Res. 2025 Mar 14;45(1):03. doi: 10.35946/arcr.v45.1.03. eCollection 2025.
7
Roles of extracellular vesicles from different origins in metabolic-associated fatty liver disease: progress and perspectives.不同来源的细胞外囊泡在代谢相关脂肪性肝病中的作用:进展与展望
Front Immunol. 2025 Mar 10;16:1544012. doi: 10.3389/fimmu.2025.1544012. eCollection 2025.
8
Immune cells in alcohol-related liver disease.酒精性肝病中的免疫细胞。
Liver Res. 2022 Jan 10;6(1):1-9. doi: 10.1016/j.livres.2022.01.001. eCollection 2022 Mar.
9
Circadian rhythms and inflammatory diseases of the liver and gut.昼夜节律与肝脏和肠道的炎症性疾病
Liver Res. 2023 Aug 16;7(3):196-206. doi: 10.1016/j.livres.2023.08.004. eCollection 2023 Sep.
10
Dysbiosis and extraintestinal cancers.肠道菌群失调与肠外癌症
J Exp Clin Cancer Res. 2025 Feb 7;44(1):44. doi: 10.1186/s13046-025-03313-x.

本文引用的文献

1
Interactions between the intestinal microbiome and liver diseases.肠道微生物组与肝脏疾病的相互作用。
Gastroenterology. 2014 May;146(6):1513-24. doi: 10.1053/j.gastro.2014.01.020. Epub 2014 Jan 15.
2
Activation of the epithelial-to-mesenchymal transition factor snail mediates acetaldehyde-induced intestinal epithelial barrier disruption.上皮-间质转化因子蜗牛的激活介导乙醛诱导的肠上皮屏障破坏。
Alcohol Clin Exp Res. 2014 Feb;38(2):344-53. doi: 10.1111/acer.12234. Epub 2013 Aug 19.
3
Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.小檗碱通过抑制肌球蛋白轻链激酶-肌球蛋白轻链磷酸化信号通路改善 IFN-γ 和 TNF-α 诱导的肠道上皮屏障功能障碍。
PLoS One. 2013 May 3;8(5):e61944. doi: 10.1371/journal.pone.0061944. Print 2013.
4
TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.TNFR2 通过激活 MLCK 依赖性紧密连接调节障碍导致细胞凋亡介导的屏障缺失和实验性结肠炎。
Gastroenterology. 2013 Aug;145(2):407-15. doi: 10.1053/j.gastro.2013.04.011. Epub 2013 Apr 22.
5
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.肠黏蛋白-2 缺乏可改善小鼠实验性酒精性肝病。
Hepatology. 2013 Jul;58(1):108-19. doi: 10.1002/hep.26321. Epub 2013 May 27.
6
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function.肝硬化患者激活的肠道巨噬细胞释放的 NO 和 IL-6 可能破坏肠道屏障功能。
J Hepatol. 2013 Jun;58(6):1125-32. doi: 10.1016/j.jhep.2013.01.038. Epub 2013 Feb 9.
7
Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment.酒精诱导的肠道微生物组病理改变的宏基因组学分析及鼠李糖乳杆菌 GG 治疗的效果。
PLoS One. 2013;8(1):e53028. doi: 10.1371/journal.pone.0053028. Epub 2013 Jan 9.
8
Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism.乙醛通过蛋白磷酸酶 2A 依赖的机制破坏 Caco-2 细胞单层中的紧密连接。
Am J Physiol Gastrointest Liver Physiol. 2012 Dec 15;303(12):G1356-64. doi: 10.1152/ajpgi.00526.2011. Epub 2012 Oct 11.
9
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.白细胞介素-1 受体拮抗剂可改善小鼠炎症小体依赖性酒精性脂肪性肝炎。
J Clin Invest. 2012 Oct;122(10):3476-89. doi: 10.1172/JCI60777. Epub 2012 Sep 4.
10
Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice.Toll 样受体 2 介导的肠道损伤和肠肿瘤坏死因子受体 I 有助于小鼠肝纤维化。
Gastroenterology. 2012 Nov;143(5):1330-1340.e1. doi: 10.1053/j.gastro.2012.07.099. Epub 2012 Jul 27.